0 Table of Contents |
1 Home |
2 Patient Information |
3 Disease Characterization |
4 Assessment |
5 Genomics |
6 Treatments |
7 Outcomes |
8 Conformance Expectations |
9 Identifying In-Scope Patients |
10 Profile Conformance |
11 USCDI+ Cancer Conformance |
12 Terminology |
13 Data Dictionary |
14 Profiles |
15 Extensions |
16 Value Sets |
17 Code Systems |
18 Capability Statements |
19 Artifacts Summary |
19.1 mCODE Data Receiver CapabilityStatement: Get in-scope patients (and associated Conditions) using _include |
19.2 mCODE Data Receiver CapabilityStatement: Get in-scope patients using reverse chaining |
19.3 mCODE Data Receiver: Get Bundle for a Patient |
19.4 mCODE Data Receiver: Get Conditions then Patients |
19.5 mCODE Data Receiver: Get Patients in Group |
19.6 mCODE Data Sender CapabilityStatement: Get in-scope patients (and associated Conditions) using _include |
19.7 mCODE Data Sender CapabilityStatement: Get in-scope patients using reverse chaining |
19.8 mCODE Data Sender: Get Bundle for a Patient |
19.9 mCODE Data Sender: Get Conditions then Patients |
19.10 mCODE Data Sender: Get Patients in Group |
19.11 Fetch mCODE Patient Bundle for a given Patient |
19.12 Search by code:in in Conditions |
19.13 Cancer Risk Assessment Profile |
19.14 Parent for T, N, and M Categories. |
19.15 ALL Risk Assessment Profile |
19.16 Body Surface Area |
19.17 Cancer Disease Status Profile |
19.18 Cancer Patient Profile |
19.19 Cancer Stage Profile |
19.20 Cancer-Related Medication Administration Profile |
19.21 Cancer-Related Medication Request Profile |
19.22 Cancer-Related Surgical Procedure Profile |
19.23 Comorbidities Profile |
19.24 Deauville Scale Profile |
19.25 ECOG Performance Status Profile |
19.26 Genomic Region Studied Profile |
19.27 Genomic Variant Profile |
19.28 Genomics Report Profile |
19.29 Histologic Behavior and Type |
19.30 Histologic Grade |
19.31 History of Metastatic Cancer |
19.32 Human Specimen Profile |
19.33 Karnofsky Performance Status Profile |
19.34 Lansky Play Performance Status Profile |
19.35 Lymphoma Stage Profile |
19.36 mCODE Patient Bundle Profile |
19.37 mCODE Patient Group Profile |
19.38 Primary Cancer Condition Profile |
19.39 Radiotherapy Course Summary Profile |
19.40 Radiotherapy Volume Profile |
19.41 Rhabdomyocaroma Risk Assessment Profile |
19.42 Secondary Cancer Condition Profile |
19.43 TNM Distant Metastases Category Profile |
19.44 TNM Primary Tumor Category Profile |
19.45 TNM Regional Nodes Category Profile |
19.46 TNM Stage Group Profile |
19.47 Tumor Marker Test Profile |
19.48 Tumor Morphology Report |
19.49 Tumor Profile |
19.50 Tumor Size Profile |
19.51 Body Structure Identifier Profile |
19.52 Body Location Qualifier Extension |
19.53 Cancer Disease Status Evidence Type Extension |
19.54 Histology-Morphology-Behavior Extension |
19.55 Laterality Qualifier Extension |
19.56 Normalization Basis Extension |
19.57 Procedure Intent Extension |
19.58 Radiotherapy Dose Delivered To Volume Extension |
19.59 Radiotherapy Modality And Technique Extension |
19.60 Radiotherapy Modality Extension |
19.61 Radiotherapy Number of Sessions Extension |
19.62 Radiotherapy Technique Extension |
19.63 Related Condition Absent Extension |
19.64 Related Condition Extension |
19.65 Treatment Termination Reason Extension (deprecated) |
19.66 Acute Lymphoblastic Leukemia (ALL) Risk Assessment Value Set |
19.67 Benign Neoplasm of Brain and CNS Disorder Value Set |
19.68 Binet Stage Value Set |
19.69 Body Location and Laterality Qualifier Value Set |
19.70 Body Location Qualifier Value Set |
19.71 Brachytherapy High Dose Rate Electronic Technique Value Set |
19.72 Brachytherapy High Dose Rate Technique Value Set |
19.73 Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set |
19.74 Brachytherapy Modality Value Set |
19.75 Brachytherapy Permanent Seeds Technique Value Set |
19.76 Brachytherapy Pulsed Dose Rate Technique Value Set |
19.77 Brachytherapy Radiopharmaceutical Technique Value Set |
19.78 Brachytherapy Technique Value Set |
19.79 Breslow Depth Stage Value Set |
19.80 Cancer Body Location Value Set |
19.81 Cancer Disease Status Evidence Type Value Set |
19.82 Cancer Disorder Value Set |
19.83 Cancer Stage Type Value Set |
19.84 Cancer Stage Value Set |
19.85 Cancer Staging Method Value Set |
19.86 Cancer Staging Prognostic Factors Types |
19.87 Cancer Staging Prognostic Factors Value |
19.88 Cancer-Related Surgical Procedure Value Set |
19.89 Carbon Ion Beam Technique Value Set |
19.90 Carcinoma In-Situ Disorder Value Set |
19.91 Clark Level Value Set |
19.92 Clinical or Pathologic Modifier |
19.93 Condition Status Trend Maximum Value Set |
19.94 Condition Status Trend Value Set |
19.95 Cytologic Evidence of Malignancy Value Set |
19.96 Deauville Scale Value Set |
19.97 Electron Beam Technique Value Set |
19.98 FAB Classification Value |
19.99 FIGO Stage Value Set |
19.100 FIGO Staging Method Value Set |
19.101 Gleason Grade Value Set |
19.102 Histologic Behavior and Type Value Set |
19.103 Histologic Grade Value Set |
19.104 Histologic Grading System Value Set |
19.105 Histology Morphology Behavior Value Set |
19.106 History of Metastatic Malignant Neoplasm Value Set |
19.107 Human Specimen Type Value Set |
19.108 International Neuroblastoma Risk Group Staging System (INRGSS) for Neuroblastoma Risk Assessment Value Set |
19.109 International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set |
19.110 International Retinoblastoma Stage Value |
19.111 International Staging System (ISS) for Myeloma Stage Value Set |
19.112 Lansky Play Performance Status VS |
19.113 Laterality Qualifier Value Set |
19.114 Lymphoma Stage Bulky Modifier Value Set |
19.115 Lymphoma Stage Value Modifier Value Set |
19.116 Lymphoma Stage Value Set |
19.117 Lymphoma Staging System Value Set |
19.118 Melanoma In-Situ Disorder Value Set |
19.119 Neutron Beam Technique Value Set |
19.120 Normalization Basis Value Set |
19.121 Photon Beam Technique Value Set |
19.122 PRETEXT Stage Value |
19.123 Primary Cancer Disorder Value Set |
19.124 Primary Malignant Neoplasm Disorder Value Set |
19.125 Procedure Intent Value Set |
19.126 Proton Beam Technique Value Set |
19.127 Radiotherapy Modality Value Set |
19.128 Radiotherapy Technique Value Set |
19.129 Radiotherapy Treatment Location Qualifier Value Set |
19.130 Radiotherapy Treatment Location Value Set |
19.131 Radiotherapy Volume Type Value Set |
19.132 Rai Stage Value Set |
19.133 Rai Staging System Value Set |
19.134 Revised International Staging System (ISS) for Multiple Myeloma Stage Value Set |
19.135 Rhabdomyosarcoma Assessment Value Set |
19.136 Rhabdomyosarcoma Clinical Group Value |
19.137 Risk Assessment Type Value Set |
19.138 Risk Assessment Value Set |
19.139 Secondary Cancer Disorder Value Set |
19.140 Specific Diagnosis of Cancer Value Set |
19.141 Teleradiotherapy Modality Value Set |
19.142 Teleradiotherapy Technique Value Set |
19.143 TG263 ValueSet |
19.144 TNM Distant Metastases Category Value Set |
19.145 TNM Distant Metastases Maximum Value Set |
19.146 TNM Distant Metastases Staging Type Maximum Value Set |
19.147 TNM Distant Metastases Staging Type Value Set |
19.148 TNM Primary Tumor Category Value Set |
19.149 TNM Primary Tumor Maximum Value Set |
19.150 TNM Primary Tumor Staging Type Maximum Value Set |
19.151 TNM Primary Tumor Staging Type Value Set |
19.152 TNM Regional Nodes Category Value Set |
19.153 TNM Regional Nodes Maximum Value Set |
19.154 TNM Regional Nodes Staging Type Maximum Value Set |
19.155 TNM Regional Nodes Staging Type Value Set |
19.156 TNM Stage Group Maximum Value Set |
19.157 TNM Stage Group Staging Type Maximum Value Set |
19.158 TNM Stage Group Staging Type Value Set |
19.159 TNM Stage Group Value Set |
19.160 TNM Staging Method Value Set |
19.161 Treatment Termination Reason Value Set |
19.162 Tumor Marker Test Value Set |
19.163 Tumor Morphology Code Max Value Set |
19.164 Tumor Morphology Code Value Set |
19.165 Tumor Size Method Value Set |
19.166 Tumor Size Units Value Set |
19.167 Wilms Tumor Body Site Value Set |
19.168 Wilms Tumor Stage Value Set |
19.169 TG263 CodeSystem |
19.170 TG263 Concept Map |
19.171 all-risk-assessment-high |
19.172 all-risk-assessment-standard-brian-l |
19.173 binet-stage-group-B |
19.174 body-surface-area-brian-l |
19.175 body-surface-area-example |
19.176 bodyheight-jenny-m-2018-03-06 |
19.177 bodyweight-jenny-m-2018-03-16 |
19.178 bodyweight-jenny-m-2018-04-22 |
19.179 bone-marrow-aspirate-result-brian-l |
19.180 bone-marrow-biopsy-result-brian-l |
19.181 cancer-disease-status-improved |
19.182 cancer-disease-status-improved-brian-l |
19.183 cancer-disease-status-jenny-m |
19.184 cancer-patient-adam-everyman |
19.185 cancer-patient-brian-l |
19.186 cancer-patient-eve-anyperson |
19.187 cancer-patient-jenny-m |
19.188 cancer-patient-john-anyperson |
19.189 cancer-patient-lucy-child |
19.190 cancer-related-comorbidities-jenny-m |
19.191 cancer-related-comorbidities-john-anyperson |
19.192 cancer-related-medication-admin-cyclophosphamide-brian-l |
19.193 cancer-related-medication-admin-cyclophosphamide-jenny-m |
19.194 cancer-related-medication-admin-doxorubicin-jenny-m |
19.195 cancer-related-medication-admin-idarubicin-brian-l |
19.196 cancer-related-medication-admin-paclitaxel-jenny-m |
19.197 cancer-related-medication-admin-prednisone-brian-l |
19.198 cancer-related-medication-admin-vincristine-brian-l |
19.199 cancer-related-medication-request-anastrozole-jenny-m |
19.200 cancer-related-medication-request-cisplatin |
19.201 cancer-related-medication-request-cisplatin-stopped |
19.202 cancer-related-medication-request-cyclophosphamide-brian-l |
19.203 cancer-related-medication-request-cyclophosphamide-jenny-m |
19.204 cancer-related-medication-request-doxorubicin-jenny-m |
19.205 cancer-related-medication-request-gefitinib |
19.206 cancer-related-medication-request-idarubicin-brian-l |
19.207 cancer-related-medication-request-paclitaxel-jenny-m |
19.208 cancer-related-medication-request-prednisone-brian-l |
19.209 cancer-related-medication-request-vincristine-brian-l |
19.210 cancer-related-surgical-procedure-jenny-m |
19.211 cancer-related-surgical-procedure-lobectomy |
19.212 deauville-scale-five |
19.213 ecog-performance-status-fully-active |
19.214 ecog-performance-status-jenny-m |
19.215 family-member-history-aunt-jenny-m |
19.216 family-member-history-grandmother-brian-l |
19.217 family-member-history-sister-jenny-m |
19.218 family-member-history-uncle-jenny-m |
19.219 figo-stage-IIIA |
19.220 genomic-region-studied-jenny-m |
19.221 genomic-region-studied-stk11 |
19.222 genomic-variant-fusion |
19.223 genomic-variant-germline-deletion |
19.224 genomic-variant-jenny-m |
19.225 genomic-variant-somatic-single-nucleotide |
19.226 genomics-report-jenny-m |
19.227 genomics-report-john-anyperson |
19.228 gleason-grade-group-4 |
19.229 gx-cancer-patient-adam-anyperson |
19.230 gx-genomic-bundle-adam-anyperson |
19.231 gx-genomic-diagnostic-implication-bap1 |
19.232 gx-genomic-diagnostic-implication-pof1b |
19.233 gx-genomic-diagnostic-implication-polrmt |
19.234 gx-genomic-msi |
19.235 gx-genomic-specimen-tumornormal-normal |
19.236 gx-genomic-specimen-tumornormal-tumor |
19.237 gx-genomic-therapeutic-implication-alectinib |
19.238 gx-genomic-therapeutic-implication-brigatinib |
19.239 gx-genomic-therapeutic-implication-ceritinib |
19.240 gx-genomic-therapeutic-implication-crizotinib |
19.241 gx-genomic-therapeutic-implication-lorlatinib |
19.242 gx-genomic-tmb |
19.243 gx-genomic-variant-fusion-ETV6-RUNX1-brian-l |
19.244 gx-genomic-variant-fusion-met-alk |
19.245 gx-genomic-variant-pertinent-negative-nras-kit-braf |
19.246 gx-genomic-variant-somatic-bap1-indel |
19.247 gx-genomic-variant-somatic-cdkn2a-cnv |
19.248 gx-genomic-variant-somatic-cdkn2b-cnv |
19.249 gx-genomic-variant-somatic-kdm5d |
19.250 gx-genomic-variant-somatic-mtap |
19.251 gx-genomic-variant-somatic-mycn |
19.252 gx-genomic-variant-somatic-pof1b |
19.253 gx-genomic-variant-somatic-polrmt |
19.254 gx-genomics-report-adam-anyperson |
19.255 gx-order-tumornormal-gensop-inc |
19.256 gx-practitioner-test-pathologist |
19.257 gx-us-core-organization-gensop-inc |
19.258 hematocrit-brian-l |
19.259 hemoglobin-brian-l |
19.260 histologic-behavior-and-type-non-small-cell |
19.261 histologic-grade-intermediate |
19.262 history-of-cancer-metastatic-to-liver |
19.263 hodgkins-lymphoma-stage-IIIe |
19.264 human-specimen-left-breast-jenny-m |
19.265 human-specimen-lung |
19.266 immunophenotype-brian-l |
19.267 jenny-m-chest-wall-lymph-nodes-treatment-volume |
19.268 jenny-m-chest-wall-treatment-volume |
19.269 john-anyperson-chf |
19.270 john-anyperson-hd |
19.271 john-anyperson-treatment-volume |
19.272 karnofsky-performance-status-normal-activity |
19.273 lab-result-observation-hemoglobin |
19.274 lansky-performance-status-brian-l |
19.275 lansky-play-performance-status-twenty |
19.276 mCODE Patient Group Example |
19.277 mcode-patient-bundle-jenny-m |
19.278 melanoma-breslow-depth-stage |
19.279 melanoma-clark-level-4 |
19.280 multiple-myeloma-iss-stage-II |
19.281 multiple-myeloma-riss-stage-II |
19.282 neuroblastoma-inrgss-stage-MS |
19.283 neuroblastoma-inss-stage-III |
19.284 no-history-of-metastatic-cancer |
19.285 observation-smoking-pack-years-jenny-m |
19.286 primary-cancer-condition-breast |
19.287 primary-cancer-condition-brian-l |
19.288 primary-cancer-condition-cll |
19.289 primary-cancer-condition-jenny-m |
19.290 primary-cancer-condition-nonspecific |
19.291 primary-cancer-condition-nsclc |
19.292 radiotherapy-treatment-summary-chest-wall-jenny-m |
19.293 radiotherapy-treatment-summary-other-with-text |
19.294 rai-stage-II |
19.295 rhabdomyosarcoma-clinical-group-stage-IA |
19.296 rhabdomyosarcoma-risk-assessment-low |
19.297 secondary-cancer-condition-brain-mets |
19.298 tnm-clinical-distant-metastases-category-cM0 |
19.299 tnm-clinical-distant-metastases-category-jenny-m |
19.300 tnm-clinical-primary-tumor-category-cT3 |
19.301 tnm-clinical-primary-tumor-category-jenny-m |
19.302 tnm-clinical-regional-nodes-category-cN3 |
19.303 tnm-clinical-regional-nodes-category-jenny-m |
19.304 tnm-clinical-stage-group-3c |
19.305 tnm-clinical-stage-group-jenny-m |
19.306 tnm-pathologic-distant-metastases-category-jenny-m |
19.307 tnm-pathologic-primary-tumor-category-jenny-m |
19.308 tnm-pathologic-regional-nodes-category-jenny-m |
19.309 tnm-pathologic-stage-group-jenny-m |
19.310 tumor-lobular-carcinoma-left-breast |
19.311 tumor-marker-test-egf |
19.312 tumor-marker-test-er-jenny-m |
19.313 tumor-marker-test-her2-jenny-m |
19.314 tumor-marker-test-oncotype-dx-jenny-m |
19.315 tumor-marker-test-pr-jenny-m |
19.316 tumor-morphology-report-non-small-cell-intermediate-grade |
19.317 tumor-size-jenny-m |
19.318 tumor-size-pathology |
19.319 tumor-specimen-left-breast-jenny-m |
19.320 tumor-specimen-lobular-carcinoma-left-breast |
19.321 us-core-condition-anxiety-jenny-m |
19.322 us-core-condition-atrial-septal-defect-brian-l |
19.323 us-core-condition-depression-jenny-m |
19.324 us-core-condition-hypertension-jenny-m |
19.325 us-core-diagnosticreport-cbc-brian-l |
19.326 us-core-diagnosticreport-lab-jenny-m |
19.327 us-core-lumbar-puncture-result-brian-l |
19.328 us-core-observation-lab-neutrophils-jenny-m |
19.329 us-core-observation-lab-sentinel-nodes-jenny-m |
19.330 us-core-observation-lab-tumor-dcis-jenny-m |
19.331 us-core-observation-lab-tumor-grade-jenny-m |
19.332 us-core-observation-lab-tumor-invasion-jenny-m |
19.333 us-core-observation-lab-tumor-margins-jenny-m |
19.334 us-core-organization-bedrock-medicine |
19.335 us-core-organization-physician-services-inc |
19.336 us-core-practitioner-jane-radiotech |
19.337 us-core-practitioner-kyle-anydoc |
19.338 us-core-practitioner-mary-obgyn |
19.339 us-core-practitioner-nancy-oncology-nurse |
19.340 us-core-practitioner-owen-oncologist |
19.341 us-core-practitioner-peter-pathologist |
19.342 us-core-procedure-biopsy-jenny-m |
19.343 us-core-procedure-bone-marrow-aspiration-brian-l |
19.344 us-core-procedure-bone-marrow-biopsy-brian-l |
19.345 us-core-procedure-lumbar-puncture-brian-l |
19.346 us-core-procedure-mammogram-jenny-m |
19.347 us-core-smokingstatus-jenny-m |
19.348 white-blood-cell-brian-l |
19.349 wilms-tumor-stage-III |
20 Basic Examples |
21 Genomics Examples |
22 Extended Example |
23 Extended Pediatric Example |
24 Release Notes |
25 Glossary |
26 Download Specification |
27 mCODE Implementation Guide Resource |